We currently work in Oregon, Canada, and Saint Vincent and the Grenadines to help support psychedelics research and wellness initiatives.
PsyDelta is the psychedelics-focused regulatory service by CannDelta Inc. PsyDelta is a team of nearly twenty Senior and Associate psychedelics and pharmaceutical consultants, each with PhD or MSc degrees. PsyDelta (by CannDelta) was founded by former Health Canada Employees of the Medical Cannabis Program, the Office of Controlled Substances, the Health Products Branch and the Drug Analysis Lab.
PsyDelta has assisted dozens of clients in navigating the regulatory framework for the Office of Controlled Substances, specifically to assist clients in acquiring access to psychedelic substances for the purposes of research, cultivation, propagation, storage, distribution, extraction, destruction, and analytical testing. We have a strong understanding of psychedelic drug reform and the new regulatory frameworks; we are here to teach you. Let us help you to start a compliant business in the exciting and bullish world of psychedelics.
At PsyDelta, we will assist you with concerns surrounding your Dealer’s Licence application. We will guide you with every aspect of your business as it pertains to site suitability and zoning, floor plan design, physical security compliance, pre-clinical research and clinical trials.
PsyDelta has previously worked with several clients in Canada and the US. Most recently, PsyDelta consulted on an exciting project in Saint-Vincent and the Grenadines for medical psychedelics access. In this work, PsyDelta created a set of Standard Operating Procedures for Psilocybin Cultivation, Propagation, & Extraction that comply with the legal psilocybin access.
Our expert team of Health Canada consultants are academics with experience that speaks for itself. Check our team page to learn about who you will be working with!
PsyDelta was founded by former Heath Canada employees. Originating from CannDelta regulatory cannabis consulting firm, PsyDelta has the experience that years of consulting in a highly regulated industry can bring. Now, our experienced consultants are helping others in the psychedelics emerging industry. Our ramp-up process is designed to empower your technical team and outfit them with the tools they need to succeed by building a new business.
Our service includes a comprehensive psychedelic business consult to help identify gaps and opportunities, a comprehensive report that includes a project plan with timelines and milestones, a cost analysis, and a schedule. We also offer a suite of services that will help you get there quickly and smoothly.
Ask us about:
- US and Canadian Psychedelics Policy
- Facility build and Design including GMP compliance
- Licensed Dealer Applications (also called a Dealer’s Licence or LD)
- Section 56 Exemptions
- Extraction Technologies and Analytical Testing
- Applications to the Office of Controlled Substances with Health Canada
Why Our Psychedelic Business Consulting Firm?
Psychedelics and cannabis business mentors are key—beginning a new business in an industry that is still very in its infancy requires knowledge, experience and attention to detail. PsyDelta provides the knowledge and guidance clients deserve to get their products across the finish line. As a client of PsyDelta, we will remove the guessing with an evidence-based approach that you and your investors will appreciate.
For Access and Clinical Research
Research related to psilocybin and related psychedelic products such as psilocin, DMT, MDMA (ecstasy), ketamine, ibogaine, ayahuasca, LSD, etc.. are making breakthroughs in Canada, the US, and internationally right now.
Health Canada offers licences and exemptions for those looking to possess, cultivate, propagate, harvest, extract and test.
PsyDelta and the Media
Recent Press Release by Lifeist (formerly Namaste Technologies Inc.) can be found:
A recent Press Release by Nextleaf Solutions can be found here.
A look at what CannDelta has been contracted for in Saint Vincent and the Grenadines to help support psychedelics research and wellness initiatives.